PAX6
Paired box protein Pax-6
Also known as: AN, AN1, AN2, D11S812E, PAX6_HUMAN, WAGR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P26367
- Gene
- PAX6
- Ensembl
- ENSG00000007372
- Chromosome
- 11
- Canonical length
- 422 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes paired box protein Pax-6, one of many human homologs of the Drosophila melanogaster gene prd. In addition to a conserved paired box domain, a hallmark feature of this gene family, the encoded protein also contains a homeobox domain. Both domains are known to bind DNA and function as regulators of gene transcription. Activity of this protein is key in the development of neural tissues, particularly the eye. This gene is regulated by multiple enhancers located up to hundreds of kilobases distant from this locus. Mutations in this gene or in the enhancer regions can cause ocular disorders such as aniridia and Peter's anomaly. Use of alternate promoters and alternative splicing results in multiple transcript variants encoding different isoforms. Interestingly, inclusion of a particular alternate coding exon has been shown to increase the length of the paired box domain and alter its DNA binding specificity. Consequently, isoforms that carry the shorter paired box domain regulate a different set of genes compared to the isoforms carrying the longer paired box domain. [provided by RefSeq, Mar 2019]
Canonical amino-acid sequenceUniProt
422 residues, UniProt reviewed canonical sequence.
>P26367|PAX6
1 MQNSHSGVNQ LGGVFVNGRP LPDSTRQKIV ELAHSGARPC DISRILQVSN GCVSKILGRY
61 YETGSIRPRA IGGSKPRVAT PEVVSKIAQY KRECPSIFAW EIRDRLLSEG VCTNDNIPSV
121 SSINRVLRNL ASEKQQMGAD GMYDKLRMLN GQTGSWGTRP GWYPGTSVPG QPTQDGCQQQ
181 EGGGENTNSI SSNGEDSDEA QMRLQLKRKL QRNRTSFTQE QIEALEKEFE RTHYPDVFAR
241 ERLAAKIDLP EARIQVWFSN RRAKWRREEK LRNQRRQASN TPSHIPISSS FSTSVYQPIP
301 QPTTPVSSFT SGSMLGRTDT ALTNTYSALP PMPSFTMANN LPMQPPVPSQ TSSYSCMLPT
361 SPSVNGRSYD TYTPPHMQTH MNSQPMGTSG TTSTGLISPG VSVPVQVPGS EPDMSQYWPR
421 LQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PAX6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 80 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 80 nTPM
- retina: 64 nTPM
- basal ganglia: 17 nTPM
- cerebral cortex: 17 nTPM
- amygdala: 17 nTPM
- hippocampal formation: 11 nTPM
Single-cell type
- pancreatic islet cells: 619 nCPM
- retinal amacrine cells: 493 nCPM
- müller glia: 477 nCPM
- ocular epithelial cells: 418 nCPM
- lacrimal acinar cells: 295 nCPM
- retinal horizontal cells: 232 nCPM
Immune cell
- basophil: 0.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 97 nTPM
- white matter: 25 nTPM
- cerebral cortex: 23 nTPM
- hippocampal formation: 22 nTPM
- basal ganglia: 20 nTPM
- amygdala: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PAX6.
Disease | AllUniProt
Conditions PAX6 is implicated in, by any mechanism.
- Aniridia 1 (AN1) MIM:106210
- Anterior segment dysgenesis 5 (ASGD5) MIM:604229
- Foveal hypoplasia 1 (FVH1) MIM:136520
- Keratitis hereditary (KERH) MIM:148190
- Microphthalmia/coloboma 12 (MCOPCB12) MIM:120200
- Coloboma of optic nerve (COLON) MIM:120430
- Bilateral optic nerve hypoplasia (BONH) MIM:165550
- Aniridia 2 (AN2) MIM:617141
Disease | GeneticClinVar
436 pathogenic / likely-pathogenic of 963 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Aniridia 1
- Irido-corneo-trabecular dysgenesis
- PAX6-related disorder
- Coloboma, ocular, autosomal dominant
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.17
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.82
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- animal organ morphogenesis
- astrocyte differentiation
- axon guidance
- blood vessel development
- brain development
- cell fate determination
- cellular response to leukemia inhibitory factor
- central nervous system development
- cerebral cortex regionalization
- chromatin remodeling
- commitment of neuronal cell to specific neuron type in forebrain
- cornea development in camera-type eye
- dorsal/ventral axis specification
- embryonic camera-type eye morphogenesis
- establishment of mitotic spindle orientation
- eye development
- eye photoreceptor cell development
- forebrain development
- forebrain dorsal/ventral pattern formation
- glucose homeostasis
- habenula development
- iris morphogenesis
- keratinocyte differentiation
- lacrimal gland development
- lens development in camera-type eye
- negative regulation of epithelial cell proliferation
- negative regulation of neuroblast proliferation
- negative regulation of neurogenesis
- negative regulation of neuron differentiation
- negative regulation of transcription by RNA polymerase II
- nervous system development
- neuroblast proliferation
- neuron fate commitment
- neuron migration
- pituitary gland development
- positive regulation of DNA-templated transcription
- positive regulation of epithelial cell differentiation
- positive regulation of gene expression
- positive regulation of miRNA transcription
- positive regulation of neuroblast proliferation
- positive regulation of transcription by RNA polymerase II
- regulation of asymmetric cell division
- regulation of cell migration
- regulation of timing of cell differentiation
- regulation of transcription by RNA polymerase II
- response to wounding
- retina development in camera-type eye
- salivary gland morphogenesis
- sensory organ development
- signal transduction involved in regulation of gene expression
- smoothened signaling pathway
- spinal cord motor neuron cell fate specification
- transcription by RNA polymerase II
- type B pancreatic cell differentiation
- ventral spinal cord development
- ventral spinal cord interneuron specification
- visual perception
- forebrain-midbrain boundary formation
- oligodendrocyte cell fate specification
- pancreatic A cell development
- somatic motor neuron fate commitment
Molecular functions
- chromatin DNA binding
- co-SMAD binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- histone acetyltransferase binding
- HMG box domain binding
- protein kinase binding
- R-SMAD binding
- RNA binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II core promoter sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- transcription cis-regulatory region binding
- transcription coregulator binding
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PAX6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PAX6 as an antibody target. Whether an autoantibody or antibody against PAX6 could matter depends on whether native PAX6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PAX6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PAX6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...